Sierra Vista Bank , recently announced its financial results for the Quarter ending September 30, 2009.
Very rarely do I have biotechnology plays, but once in a while I discover an opportunity so big that I must bring it to you immediately…
I believe that I potentially could have discovered the next Dendreon Corp (DNDN), which made a run from $2.55 to $30.42 this year.
I know what you are thinking, there’s no way the company I am about to tell you about will ever become the next DNDN. While the odds of me being right may be low, remember that very few people gave DNDN a chance to succeed when it was $2.55.
I am confident that if you take the time to research this company this weekend, you will agree with me that the upside potential for this stock in the short-term is astronomical. The scientific community is beginning to go crazy over their technology and I believe it’s only a matter of time before the excitement spreads to the investment community!
The company is MabCure, Inc. and it trades under the symbol MBCI. It closed last week at $1.07.
MBCI’s vision is to change the perception of cancer as a largely incurable disease!
MBCI’s first goal is the development of simple diagnostic tests for the early detection of ovarian, prostate, colorectal and breast carcinomas. Each test will be based upon highly specific monoclonal antibodies (MAbs) against a given cancer which should be able to detect unique cancer markers in the blood, urine or other body fluids. Identifying the presence of disease before it disseminates beyond its original site should lead to a 90% cure rate of these cancer patients.
MBCI owns proprietary technology for the creation of unique and highly specific MAbs, which will be developed as diagnostic tools, imaging agents, and drugs to treat lethal cancers.
MBCI recently announced a major development milestone, with the creation of its MAbs against Colorectal Cancer, a devastating disease that could be treated effectively if diagnosed at an early stage. MBCI estimates the European and U.S. market potential for this product to each be in the billion dollar range.
I consider MBCI to be at the ground-floor right now. I am one of the first in the investment community to discover it, but word is quickly spreading in the scientific community and I believe it could spread throughout the investment community in the very near-future!
MBCI was also featured in the August edition of Biotechnology Focus, Canada’s oldest and most successful magazine serving the Canadian life science industry, in an article entitled "Tumour-Specific Markers: The Holy Grail of Cancer Diagnostics". To read the article go to: http://www.bioscienceworld.ca/TumourSpecificMarkersTheHolyGrailofCancerDiagnostics
MBCI was even featured in the June 4, 2009 edition of BioWorld Today, biotech’s most respected news source for over seventeen years. The cover story, written by Jennifer Boggs and titled “MabCure’s Revamped Hybridoma Approach Seeks Cancer Antigens,” describes the company’s “new take on a classic drug discovery technology,” detailing how MBCI is developing monoclonal antibodies against difficult-to-pinpoint tumor specific antigens (TSA) for the diagnostics market.
MBCI could one day provide physicians with novel antibodies and drugs that effectively attack only cancer cells while sparing normal tissue and minimize toxic side effects!
I strongly urge you to research MBCI this weekend! While all biotech plays are by nature highly speculative, this is a one biotech play that I am extremely confident about!
—–
My firm Lebed Biz LLC has been compensated by a third-party (Wall Street Grand LLC) $25,000 cash for a one-month MBCI investor relations contract. Never invest into a stock we discuss unless you can afford to lose your entire investment. For our full disclaimer go to: www.lebed.biz/disclaimer.htm
Jonathan Lebed
Lebed.biz
Staff
| This message was sent from Jonathan Lebed to . It was sent from: Jonathan Lebed, 350 Ramapo Valley Rd, Oakland, NJ 07436. You can modify/update your subscription via the link below. |
Email Marketing by
|
|
For additional information on Penny Stocks and Hot Penny Stocks please visit here.
Weekend Update 10-31-2009
I want to wish everyone a safe and happy Halloween.
I will be announcing a new pick tomorrow, so be sure to watch for my email.
My alert on TNUS from Thursday is already up 20% in one day!!
XMDC hit a high earlier in the week for a gain of 400% in less then a month.
*************************************************
The disclaimer is to be read and fully understood before using our site, or joining our email list. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE WELL: The StockEgg.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. The third party, may have shares and may liquidate it, which may negatively affect the stock price. StockEgg.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice which may negatively affect the market. Release of Liability: Through use of this website viewing or using you agree to hold StockEgg.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise, damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. StockEgg.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and StockEgg.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. StockEgg.com, nor any of its affiliates are not registered investment advisors or a broker dealers. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead StockEgg.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. StockEgg.com does not offer such advice or analysis, and StockEgg.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, StockEgg.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, StockEgg.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. StockEgg.com is not responsible for any claims made by the companies advertised herein. Full disclaimer can be read at http://www.StockEgg.com/disclaimer.html
![Safe]()
|
![]()
|
StockEgg.com | P.O Box 8652 | Fountain Valley | CA | 92728-8652 |
|
For additional information on Penny Stocks and Hot Penny Stocks please visit here.
Weekend Update
I will be announcing a big pick Sunday night. Watch for my emails I think you will like this one.
The overall market retraced this week after the Dow broke 10k for a few days. The next support level for the Dow will be around 9,500.
Happy Halloween!
******Advertisement***********
http://www.bullrally.com – Online Broker Reviewed
****************************
*********************************************************
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
PLEASE NOTE WELL: The Hototc.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://www.Hototc.com/disclaimer.htm
Release of Liability: Through use of this website viewing or using you agree to hold Hototc.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Hototc.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Hototc.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Hototc.com, nor any of its affiliates are not registered investment advisors or a broker dealers.
None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead Hototc.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. Hototc.com does not offer such advice or analysis, and Hototc.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor’s investment may be lost or impaired due to the speculative nature of the companies profiled.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks an uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results.
In preparing this publication, Hototc.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, Hototc.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. Hototc.com is not responsible for any claims made by the companies advertised herein.
![Safe]()
|
![]()
|
Hototc.com | P.O. Box 8652 | Fountain Valley | CA | 92708 |
|
For additional information on Penny Stocks and Hot Penny Stocks please visit here.
|
|
 |
|
Wall Street Grand Report
Company: MabCure Inc. (OTCBB: MBCI)
Current PPS: $1.07
I have been on the lookout for a pick like MBCI for over 6 months! Do you know why? Do you remember DNDN? Well DNDN was one of the biggest biopharmaceutical plays in the market this year! DNDN made a spectacular run from about $2.55 to as high as $30.42 in less than 6 months for an astronomical gain of 1,092% making it one of the most remarkable TEN BAGGERS we have seen this year in the biopharamceutical sector!
Everyone is on the lookout for the next DNDN and we finally found it! MBCI is still very undiscovered by the investment community and I believe it is setting up for a HUGE breakout in the near future once they start updating everyone on their most recent developments!
Let me tell you a little about their technology. MBCI is a biotechnology company using a "re-engineered" Hybridoma methodology to create monoclonal antibodies (Mabs) for the detection of cancer at an early stage, where the cure rates are greater than 90%. MBCI has already generated highly specific Mabs against three human malignancies: melanoma, ovarian, and prostate cancers!
Unlike all other commercially available "anti-cancer" antibodies, MabCure’s Mabs uniquely target only cancer cells. These Mabs will first serve for the detection of early stage cancers and later as candidates for cancer imaging and for the development of cancer-specific drugs devoid of toxicity.
There are no blood tests or useful imaging methods that can adequately and routinely detect most types of cancers when they are at their earliest and most curable stage. MBCI has the answer to this problem!
Monoclonal antibodies (MAbs) are one of the most useful biomolecules ever discovered!
From my understanding, this all comes about by taking a piece of the persons cancer and then they clone it and form antibodies against the cancer to help the body "recognize" the cancer and fight the diseased cells. They then inject the antibodies and this in theory then gives the body a chance to kill the cancer cells using its own immune system. This has started to become a HUGE breakthrough and story across the world and MBCI is position perfectly to capitalize on it!
The challenge of producing antibodies against specific cancer antigens has eluded scientists for many decades. Modern technologies for designing antibodies against a known disease require both the identification and availability of the antigens which characterize the disease. The putative tumor-specific antigens (TSA), presumed to exist on cancer cells, have eluded identification, thus making the generation of antibodies against them through current technologies virtually impossible.
Classic Hybridoma technology is based on the generation of immortal “hybrid cells” (hybridoma), which follows the fusion of antibody-producing B-cells with myeloma tumor cells. Each hybridoma continuously “manufactures” a single type of (“monoclonal”) antibody. MBCI has "re-engineered" the classic hybridoma technology into a highly efficient and optimized one, overcoming the inherent limitations of the former, yet exploits its benefits!
MBCI hybridoma technology exhibits several important advantages over competing technologies:
- Prior identity of cancer antigen(s) is not required for generating Mabs against these antigens. MBCI’s approach to creating anti-cancer Mabs is unbiased and enhances the discovery of new cancer markers.
- Antigens are preserved in their natural conformations; the resulting Mabs are able to better recognize and bind more selectively to tumor cells.
- Unlimited quantities of antibodies produced against a selected cancer target. A large number of antibodies is the key factor for obtaining an antibody repertoire which would exhibit both tumor specificity and tumor "universality".
MBCI has successfully generated hybridoma libraries for three different cancers that produce, respectively, antibodies to melanoma, to an aggressive form of prostate cancer and to ovarian carcinoma. These antibodies have been shown to be specific and "universal" to each cancer respectively, i.e. they recognize every cancer from different individuals having that particular disease and do not react with any normal antigen tested so far. These Mabs are the first candidates for the development of novel diagnostic tools, imaging agents and drugs to treat the corresponding cancers.
MBCI’s Market Potential and Opportunity is Unbelievable!
MBCI is not one to miss out on so make sure to do as much DD as possible and spread the word to your friends before Monday!
More Updates To Come …
Help Spread the word about Wall Street Grand!
You can call us Toll free at 1888-9-Club Grand (1888-925-8247)
Offices are open Monday – Friday, 9:30 am-4:00 pm EST
|
Please make sure to REGISTER at www.WallStreetGrand.com to take full advantage of the vast benefits of WSG! |
Wall Street Grand’s stock profiles are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. Never invest into a stock we discuss unless you are prepared to lose your entire investment.WSG has been compensated Fifty Thousand Dollars by a Third Party (Capital Financial Media) for this profile on MBCI..The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country Everything stated in WSG alerts are based on my opinion. For our full disclosure please visit- http://www.wallstreetgrand.com/disclosure.html
|
 |
|
|
| This message was sent from WallStreetGrand.com to . It was sent from: Staff Wall Street Grand, Broadway, Manhattan, NY 10007. You can modify/update your subscription via the link below. |
Email Marketing by
|
|
For additional information on Penny Stocks and Hot Penny Stocks please visit here.
|
|
|
You are subscribed as
|
Weekend Update
Dear Members,
Monday we have our affiliated site, BoldStocks.com with their latest BOLD STOCK PICK.
I wanted to share the following cartoon relavent to today’s fun holiday. Also – HINT # 1 OF 3 for THE BOLD STOCK.
Below is the message from “MR. BOLD”
Thanks,
John Pentony
Publisher, StockGuru
Bold Stocks – Great Halloween Cartoon – and Hint #1 of 3 for Monday’s Bold Stock
First… Happy Halloween!
Next Bold Stock: Announcing Monday, November 2nd at 9:30 AM ET
Dear Members:
I am putting out three weekend hints on our Monday Bold Stock. Before the hint, make sure you get the link for Monday bookmarked…
Here is the link:
http://www.boldstocks.com/alert/
Hint # 1:
A one word hint: Could not be more timely.
I am not going to further explain the hint. On Monday when you hear the story and see the ticker you will understand how all three hints make one great stock!
NEXT HINT SUNDAY!
AGAIN BOOKMARK THE LINK; SET YOUR ALARM ON YOUR CELL PHONE TO REMIND YOU; GO TO THIS LINK ON MONDAY AT 9:25 AM ET:
http://www.boldstocks.com/alert/
ALWAYS TRADE BOLD!
Mr. Bold
Get BOLD STOCKS on TWITTER:
http://twitter.com/boldstocks
Get The BOLD STOCKS RSS FEED:
http://www.boldstocks.com/feed/
StockGuru is in its Seventh Year!
We started many years ago as TheStockGuru.com. We upgraded to this web site name in 2003. Total membership to our site has been over 400,000 registered members. That is adding up anyone and everyone who has been on our lists at one time. We still have a huge number that are still very much active.
Over the years I have tried to bring quality stocks and great information to my members. Information is the key. In that regard I started Shareholder Vision three years ago. I think seeing a company from the outside looking in is one of the best ways to get to know a company.
We also own Street Research. Our goal here is to hire the best independent analysts to look at select companies. There just is nobody covering NASDAQ Bulletin Board stocks for ‘free’. That means our service is very much needed, and we do about one or two companies per month with our research.
We have a number of changes that we are launching as this new year begins. I think it is critical to invest far more wisely in such a market, but I do believe that if this market continues the very recent trend toward stability, we could look at some very big gains on quality companies in the new year.
Thanks for staying with us! We are all in it together. We are now entering this seventh year with a great deal of excitement.
Happy New Year from My Family to You and Yours!
John Pentony
Publisher, StockGuru.com
|
Live Twitter Alerts All Market Day
Our Twitter Feed includes all live posts from StockGuru.com.
Featured on StockGuru
While we cover many companies, here are our current featured profiles on StockGuru:
Medizone International Inc. (OTCBB: MZEI)
Quasar Aerospace Industries (OTC: QASP)
Skinvisible, Inc.
(OTCBB: SKVI)
DecisionPoint Systems, Inc. (OTCBB: DNPI)
StockGuru Spotlight Alerts
Here are our latest Spotlight Alerts. Note that we typically do NOT email these to members. You must visit the site at THIS LINK to keep up to date; or you may subscribe to THIS RSS FEED.
Suggest a Client:
Do you know a great company that simply must be featured on StockGuru or Shareholder Vision?
Suggest it to us.
Email: john@stockguru.com
Tel: (469) 252-3031.
|
|
|
|
|
For additional information on Penny Stocks and Hot Penny Stocks please visit here.
|
|
|
You are subscribed as
|
Weekend Update
Dear Members,
Monday we have our affiliated site, BoldStocks.com with their latest BOLD STOCK PICK.
I wanted to share the following cartoon relavent to today’s fun holiday. Also – HINT # 1 OF 3 for THE BOLD STOCK.
Below is the message from “MR. BOLD”
Thanks,
John Pentony
Publisher, StockGuru
Bold Stocks – Great Halloween Cartoon – and Hint #1 of 3 for Monday’s Bold Stock
First… Happy Halloween!
Next Bold Stock: Announcing Monday, November 2nd at 9:30 AM ET
Dear Members:
I am putting out three weekend hints on our Monday Bold Stock. Before the hint, make sure you get the link for Monday bookmarked…
Here is the link:
http://www.boldstocks.com/alert/
Hint # 1:
A one word hint: Could not be more timely.
I am not going to further explain the hint. On Monday when you hear the story and see the ticker you will understand how all three hints make one great stock!
NEXT HINT SUNDAY!
AGAIN BOOKMARK THE LINK; SET YOUR ALARM ON YOUR CELL PHONE TO REMIND YOU; GO TO THIS LINK ON MONDAY AT 9:25 AM ET:
http://www.boldstocks.com/alert/
ALWAYS TRADE BOLD!
Mr. Bold
Get BOLD STOCKS on TWITTER:
http://twitter.com/boldstocks
Get The BOLD STOCKS RSS FEED:
http://www.boldstocks.com/feed/
StockGuru is in its Seventh Year!
We started many years ago as TheStockGuru.com. We upgraded to this web site name in 2003. Total membership to our site has been over 400,000 registered members. That is adding up anyone and everyone who has been on our lists at one time. We still have a huge number that are still very much active.
Over the years I have tried to bring quality stocks and great information to my members. Information is the key. In that regard I started Shareholder Vision three years ago. I think seeing a company from the outside looking in is one of the best ways to get to know a company.
We also own Street Research. Our goal here is to hire the best independent analysts to look at select companies. There just is nobody covering NASDAQ Bulletin Board stocks for ‘free’. That means our service is very much needed, and we do about one or two companies per month with our research.
We have a number of changes that we are launching as this new year begins. I think it is critical to invest far more wisely in such a market, but I do believe that if this market continues the very recent trend toward stability, we could look at some very big gains on quality companies in the new year.
Thanks for staying with us! We are all in it together. We are now entering this seventh year with a great deal of excitement.
Happy New Year from My Family to You and Yours!
John Pentony
Publisher, StockGuru.com
|
Live Twitter Alerts All Market Day
Our Twitter Feed includes all live posts from StockGuru.com.
Featured on StockGuru
While we cover many companies, here are our current featured profiles on StockGuru:
Medizone International Inc. (OTCBB: MZEI)
Quasar Aerospace Industries (OTC: QASP)
Skinvisible, Inc.
(OTCBB: SKVI)
DecisionPoint Systems, Inc. (OTCBB: DNPI)
StockGuru Spotlight Alerts
Here are our latest Spotlight Alerts. Note that we typically do NOT email these to members. You must visit the site at THIS LINK to keep up to date; or you may subscribe to THIS RSS FEED.
Suggest a Client:
Do you know a great company that simply must be featured on StockGuru or Shareholder Vision?
Suggest it to us.
Email: john@stockguru.com
Tel: (469) 252-3031.
|
|
|
|
|
For additional information on Penny Stocks and Hot Penny Stocks please visit here.
|
|
| |
|
Wall Street Grand Report
Company: MabCure Inc. (OTCBB: MBCI)
Current PPS: $1.07
We have a new pick for everyone to research this weekend that is way ahead of its time! I hope everyone is enjoying their Halloween but consider this your treat because I believe it is the next pick on our list that is poised to become new big winner for us in 2009!
The company I am referring to is MabCure Inc. trading on the Over the Counter Bulletin Board under ticker symbol MBCI. MBCI closed on Friday at $1.07 and is a very liquid issue trading an average daily volume of over 476k in volume.
I have been on the lookout for a pick like MBCI for over 6 months! Do you know why? Do you remember DNDN? Well DNDN was one of the biggest biopharmaceutical plays in the market this year! DNDN engages in the discovery, development, and commercialization of therapeutics to enhance cancer treatment options for patients. The company’s product portfolio includes active cellular immunotherapy, monoclonal antibody, and small molecule product candidates to treat various cancers. DNDN made a spectacular run from about $2.55 to as high as $30.42 in less than 6 months for an astronomical gain of 1,092% making it one of the most remarkable TEN BAGGERS we have seen this year!
After spending months of researching looking for what possibly could become the next DNDN we finally found it and it’s MBCI!
Do not waste any time and start researching MBCI RIGHT NOW!
In spite of major advances over the past 20 years, cancer remains one of the most deadly diseases with unimpressive "cure" rates. The billions of dollars spent over the past few decades have led to only modest gains in the fight against cancer. Effective treatment of most cancers is limited by the toxic effects of chemotherapy, radiotherapy, or antibody-based drugs which are not cancer-specific. There is a clear need for developing a new strategy against incurable cancers. One possible approach is to develop means for more effective diagnosis of early stage cancer; the other is to create more potent and specific drugs against advanced cancer.
MBCI is a biotechnology company whose vision is to change the perception of cancer as a largely incurable disease. MBCI’s primary mission is to develop novel diagnostics for the early detection of cancer when the disease is still localized and treatable, and where the chances for cure are greater than 90 percent!
Most “killer” cancers such as ovarian, colorectal, breast, lung, and prostate carcinomas owe their lethality to late diagnosis when the disease has already spread beyond its original site.
According to the American Cancer Society, most patients have more than a 90% chance of 5-year survival when cancer is detected early. The only example of an effective early detection test is the PAP smear which has brought about a significant reduction in cervical cancer morbidity and mortality. However, similar methods for screening and diagnosing most cancers in their early stage remain elusive.
MBCI is a company whose vision is to change the perception of cancer as a largely incurable disease. MabCure’s scientists believe that the key to early detection of cancer by antibodies lies in their ability to identify putative tumor markers or tumor-specific antigens (TSA), present on the surface of these cells. Using its proprietary technology, MBCI has created unique and highly specific Mabs against several cancers (e.g. ovarian and prostate carcinomas) which could potentially identify these diseases in their earliest stage! The development of unique and highly specific diagnostic tests could lead to far earlier diagnoses than has ever been possible which, in turn, will bring curing cancers closer to clinical reality.
Beyond the initial focus on developing diagnostic tests, MBCI’s strategic plan calls for the application of its proprietary cancer-specific Mabs in three additional areas:
- The imaging of cancer
- Immunotherapy of cancer
- Discovery of novel cancer markers (tumor specific antigens), which can lead to the development of potent anti-cancer drugs.
In summary, MBCI’s first goal is the development of simple diagnostic tests for the early detection of ovarian, prostate, colorectal and breast carcinomas. Each test will be based upon specific Mabs against a given cancer which should be able to detect unique cancer markers in the blood, urine or other body fluids. Identifying the presence of disease before it disseminates beyond its original site should lead to a 90% cure rate of these cancer patients.
Start your due diligence right away on MBCI and get ready for another HUGE winner to be added to our track record! Don’t miss out on Monday!
More Updates To Come …
Help Spread the word about Wall Street Grand!
You can call us Toll free at 1888-9-Club Grand (1888-925-8247)
Offices are open Monday – Friday, 9:30 am-4:00 pm EST
|
Please make sure to REGISTER at www.WallStreetGrand.com to take full advantage of the vast benefits of WSG! |
Wall Street Grand’s stock profiles are intended to be stock ideas, NOT recommendations. Please do your own research before investing. It is crucial that you at least look at current SEC filings and read the latest press releases. Information contained in this profile was extracted from current documents filed with the SEC, the company web site and other publicly available sources deemed reliable. The purpose of this advertisement, like any advertising, is to provide coverage and awareness for the company. Never invest into a stock we discuss unless you are prepared to lose your entire investment.WSG has been compensated Fifty Thousand Dollars by a Third Party (Capital Financial Media) for this profile on MBCI..The information provided in this advertisement is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject us to any registration requirement within such jurisdiction or country Everything stated in WSG alerts are based on my opinion. For our full disclosure please visit- http://www.wallstreetgrand.com/disclosure.html
|
|
|
|
| This message was sent from WallStreetGrand.com to . It was sent from: Staff Wall Street Grand, Broadway, Manhattan, NY 10007. You can modify/update your subscription via the link below. |
Email Marketing by
|
|
For additional information on Penny Stocks and Hot Penny Stocks please visit here.
|
View this email online: Click here to read this newsletter online |
|
 |
 |
|
Urgent Alert from BoldStocks.com
Share This Alert with Traders You Know! |
You are subscribed as
|
|
 |
 |
 |
|
First… Happy Halloween!
Next Bold Stock: Announcing Monday, November 2nd at 9:30 AM ET
Dear Members:
I am putting out three weekend hints on our Monday Bold Stock. Before the hint, make sure you get the link for Monday bookmarked…
Here is the link:
http://www.boldstocks.com/alert/
Hint # 1:
A one word hint: Could not be more timely.
I am not going to further explain the hint. On Monday when you hear the story and see the ticker you will understand how all three hints make one great stock!
NEXT HINT SUNDAY!
AGAIN BOOKMARK THE LINK; SET YOUR ALARM ON YOUR CELL PHONE TO REMIND YOU; GO TO THIS LINK ON MONDAY AT 9:25 AM ET:
http://www.boldstocks.com/alert/
ALWAYS TRADE BOLD!
Mr. Bold
|
|
Get BOLD STOCKS on TWITTER:
http://twitter.com/boldstocks
Get The BOLD STOCKS RSS FEED:
http://www.boldstocks.com/feed/
 |
To stop receiving these emails please .
Type your Company Name,Bold Stocks (”Bold”) provides its members with the latest news, press releases, and research reports for all the companies highlighted on our web site, www.BoldStocks.com. Bold utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by Bold to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions. They may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. Bold encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Bold makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Bold is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed onhttp://www.boldstocks.com or mentioned herein. This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies= annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and Bold undertakes no obligation to update such statements. Pentony Enterprises LLC is occassionally compensated for coverage. When this is the case, we indicate clearly with a disclosure of all compensation received in the past and present, plus we also disclose any anticipated compensation in the future. Compensation is typically in cash. Sometimes a third party shareholder pays us in free trading shares. Sometimes a company pays us in restricted shares. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.
|
|
|
|
|
 |
|
To stop receiving these emails please .
For additional information on Penny Stocks and Hot Penny Stocks please visit here.
MUMBAI, India—-Patni Computer Systems Limited today announced its financial results for the third quarter ended 30th September 2009.
Next Page »
View message 
Comment on this message 
Receive as RSS 
del.icio.us 
Digg 
reddit 
Facebook 
StumbleUpon 
